Stock AnalizEnsign Group, Inc. ENSG
Hospital/Nursing Management · IPO 2007 · data as of November 13, 2026
Ensign Group, Inc. (ENSG) is a healthcare company listed in the US with a market value of about $11.0B. In the twelve months to September 30, 2026 it had revenue of $5.7B and net income of $399M, a net margin of 7.0%.
Its overall Stock Analiz score is 2.6 out of 5 (average). The strongest part is track record (4/5); the weakest is value (0/5).
Key numbers: a P/E of 28.0, a price to free cash flow of 52.3, 5-year revenue growth of 16% a year, a 5-year average ROIC of 7%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 51% below the current price.
Score: 2.6 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
- Profitable 5 years in a row
- ROE above 15%
- Positive free cash flow
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.7B | $5.1B | $4.3B | $3.7B | $3.0B | $2.6B | $2.4B | $2.0B | $1.8B | $1.6B | $1.7B |
| Net income | $399M | $344M | $298M | $209M | $225M | $195M | $170M | $111M | $92M | $40M | $50M |
| Free cash flow | $210M | — | — | — | — | — | — | $121M | $159M | $25M | $8M |
| EPS (diluted) | $6.72 | $5.84 | $5.12 | $3.65 | $3.95 | $3.42 | $3.06 | $1.97 | $1.70 | $0.77 | $0.96 |
| Net margin | 7.0% | 6.8% | 7.0% | 5.6% | 7.4% | 7.4% | 7.1% | 5.4% | 5.3% | 2.5% | 3.0% |
| ROIC | — | 7.2% | 7.3% | 5.8% | 8.2% | 8.7% | 9.1% | 5.1% | 8.3% | 2.9% | 7.6% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 5 analysts is $225.80, 20% above the current price; targets range from $210.00 to $240.00; the consensus rating is “Buy”; expected EPS is $7.98 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Ensign Group’s P/E ratio?
About 28.0, based on the last twelve months of diluted earnings per share (forward P/E about 21.7).
Is Ensign Group stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 51% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Ensign Group pay a dividend?
Yes. The dividend yield is about 0.14%, and it has paid dividends for 10 years in our data.
Is Ensign Group a good stock to buy?
We do not give buy or sell advice. Ensign Group scores 2.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.